TargED Biopharmaceuticals

TargED

This biotechnology company develops targeted biological drugs that deliver enzymes to blood clots to treat patients with various forms of thrombosis.

Aptatargets

The company develops aptamer-based therapeutic drugs for patients with acute ischemic stroke and other inflammatory or cardiovascular diseases.

Basking Biosciences

The company develops reversible therapies targeting von Willebrand Factor for patients with acute thrombotic conditions, such as strokes.

HemostOD

The company develops stem cell-derived platelets for transfusion and targeted drug delivery, serving healthcare providers and pharmaceutical partners treating blood disorders or trauma.

Acticor Biotech

The company develops glenzocimab, a therapeutic antibody fragment for treating patients with acute ischemic stroke and other thrombotic diseases.

Biomedical Solutions

This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

Theratome Bio

This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.